Staff

Panduan Perkhidmatan Farmakokinetik Klinikal di Klinik Kesihatan Kementerian Kesihatan Malaysia

Date: 23 July 2024 - 6:46am

Clinical pharmacokinetic services at health clinics are important to ensure that medications are within the recommended therapeutic range and to monitor the effectiveness, toxicity, and patient medication adherence.

English

Guidelines for Reviewers - Journal of Pharmacy Quality Improvement Initiatives (PharmQIIs)

Date: 2 July 2024 - 8:06am

The Journal of Pharmacy Quality Improvement Initiatives (PharmQIIs) is a peer-reviewed journal published by the Pharmaceutical Services Programme (PSP), Ministry of Health Malaysia (MOH) since 2022. PharmQIIs is set to publish manuscripts derived from Quality Improvement Initiatives (QIIs) that are conducted in Quality Improvement Reports (QIR) format.

Kempen Tolak Ubat Tidak Sah (TOBaTS)

Date: 14 June 2024 - 9:35am

 

 

 

 

 

 

 

 

The “TOLAK UBAT TIDAK SAH” campaign, officially abbreviated as “TOBaTS,” is a new initiative by the Pharmacy Enforcement Division , Ministry of Health (MOH) to combat the issue of illegal supply and sale of medicines in Malaysia.

27th PIC/S Expert Circle Meeting On Human Blood, Tissues, Cells and Advance Therapy Medicinal Products (ATMPs)

Pleased to be informed that the NPRA will organize the 27th PIC/S Expert Circle Meeting On Human Blood, Tissues, Cells and Advance Therapy Medicinal Products (ATMPs) on 20-22 August 2024.

For more information, download the provided attachment.

Location/place: 
Kuala Lumpur, Malaysia
Date: 
Tuesday, 20 August 2024 to Thursday, 22 August 2024

Geriatric Pharmacy Protocol

Date: 20 May 2024 - 9:56am

The Geriatric Pharmacy Protocol is the second edition published under the Pharmaceutical Services Program of the Ministry of Health Malaysia (MOH)

English

DILUTION GUIDE FOR FLUID RESTRICTED CRITICALLY ILL ADULTS

Date: 19 December 2025 - 8:30am

Critically ill patients are individuals with severe and often life-threatening medical conditions that require round-the-clock monitoring and care by a specialized team of healthcare professionals.

English

What can I do if I have enquiry or would like to get explanation on the approved format by MAB?

Applicants can reach out officers in the secretariat through multiple ways such as phone call (03-7841 3200), email (liu@moh.gov.my), letter or face-to-face meet up if they have enquiry on the approved format. Reasons/ justifications for cancellation of statements or words in the approved advertisement formats or rejection of advertisements will be explained by officers to you. 

What is the difference between the new guidelines and old guidelines?

The main difference in the new GP is the insertion of examples to better explain the context of the GP. Besides, the new GP also consolidates infographic of decision tree, guideline to fill up the application form, application form for new application and amendment, format of celebrity endorsement and customer testimony and the appeal notice to Minister of Ministry of Health Malaysia. 

There are also changes in the provisions within the new guidelines, such as press release of NCE products is now allowed to be published more than one time; supplement products are allowed to be offered as gift for the purchase of the same product; and mandatory statement “This is a medicine/ supplement/ traditional product” has been removed from advertisement format has also been stated in the new guidelines.
 

Are advertisements related to disease awareness program are allowed?

Disease awareness programmes or health education campaign aiming to create awareness on health and diseases without promoting health products is permissible as there are no violations under S4B Medicines (Advertisement & Sale) Act 1956. The organizers should always ensure that no advertisements related to medicinal products are displayed or exhibited during the program.

Pages